Tag: Organ Transplants

Favorable outcomes, minimal adverse effects seen in solid organ transplant recipients who received monoclonal antibody therapy for COVID-19

Nonlisted patients disproportionally African American, lack commercial insurance, or reside in lower-income communities

Six patients with low-positive antibody levels following standard vaccination achieved high-positive levels after dose 3

But few kidney transplant recipients develop anti-spike SARS-CoV-2 antibodies after second mRNA vaccine dose

Five-year mortality did not differ for adults aged ≥70 years and <70 years after adjustment for relevant confounders

Pharmacist-led intervention cuts medication errors and hospitalizations

Fifty-four percent of solid organ transplant recipients had antibody response after two doses of SARS-CoV-2 mRNA vaccine

Risk for nonanastomotic biliary strictures following transplant lower with hypothermic oxygenated machine perfusion of deceased donor liver

Ratio of IL-10/TNFα produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year

Patients with kidney failure associated with sickle cell disease are less likely to receive a transplant despite similar reduction in mortality